Target Price | $4.13 |
Price | $2.41 |
Potential |
71.16%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Akoya Biosciences Inc 2025 .
The average Akoya Biosciences Inc target price is $4.13.
This is
71.16%
register free of charge
$5.00
107.47%
register free of charge
$3.50
45.23%
register free of charge
|
|
A rating was issued by 7 analysts: 3 Analysts recommend Akoya Biosciences Inc to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Akoya Biosciences Inc stock has an average upside potential 2025 of
71.16%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 96.63 | 86.10 |
29.08% | 10.90% | |
EBITDA Margin | -48.78% | -35.83% |
38.17% | 26.55% |
7 Analysts have issued a sales forecast Akoya Biosciences Inc 2024 . The average Akoya Biosciences Inc sales estimate is
This results in the following potential growth metrics:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.43 | -1.01 |
23.53% | 29.37% | |
P/E | negative | |
EV/Sales | 1.95 |
3 Analysts have issued a Akoya Biosciences Inc forecast for earnings per share. The average Akoya Biosciences Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Akoya Biosciences Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Akoya Biosciences Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.